KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dynavax Technologies (DVAX) Notes Payables (2025)

Historic Notes Payables for Dynavax Technologies (DVAX) over the last 3 years, with Q3 2025 value amounting to $40.1 million.

  • Dynavax Technologies' Notes Payables changed N/A to $40.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $40.1 million, marking a year-over-year change of. This contributed to the annual value of $12.8 million for FY2011, which is N/A changed from last year.
  • Latest data reveals that Dynavax Technologies reported Notes Payables of $40.1 million as of Q3 2025.
  • In the past 5 years, Dynavax Technologies' Notes Payables registered a high of $40.1 million during Q3 2025, and its lowest value of $40.0 million during Q2 2025.